Craig T Jordan

23PUBLICATIONS
140CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Planning and decision makingInformation visualisationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 08, 2026
Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

|Jul 24, 2026
A phase 1/1b study of the all-oral regimen CC-486 and venetoclax in acute myeloid leukemia.

|Jul 21, 2026
The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells.

|Dec 19, 2025
Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapse.

Tzu-Chieh Ho, Mark W LaMere, Hiroki Kawano

|Dec 02, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine.

Nazmul Islam, Justin L Dale, Jamie S Reuben

|Jun 12, 2025
scExploreR: a flexible platform for democratized analysis of multimodal single-cell data by non-programmers.

William M Showers, Jairav Desai, Stephanie R Gipson

Pageof 4

Frequent Collaborators

8 joint publications

Daniel Pollyea

7 joint publications

Clayton A Smith

6 joint publications

Angelo D'Alessandro

5 joint publications

Austin E Gillen